Advertisement
Product › Details
SomaScan® protein measurement platform using DNA measurement solution
Next higher product group | proteomic technology_o | |
Status | 2019-04-30 existent | |
Organisation | SomaLogic Inc. (NASDAQ: SLGC) | |
Agilent Technologies Inc.. (4/30/19). "Press Release: Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays". Santa Clara, CA & Boulder, CO.
Use of Agilent's custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development
Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company) today announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for use in the nucleic acid detection step within SomaLogic's novel SOMAscan assay, a protein measurement platform with applications across basic and clinical research, diagnostics, and pharmaceutical discovery and development.
SomaLogic's SOMAscan assay solves a protein measurement challenge using a DNA measurement solution, enabling the accurate measurement of an individual's protein makeup with unequalled sensitivity and dynamic range. The customized Agilent microarray, which is based on SomaLogic's specifications, is incorporated into the SOMAscan assay which is used to detect and measure 5,000 proteins accurately and reproducibly from a small volume of biological sample.
"Agilent and SomaLogic have developed a mutually rewarding partnership over the years, and we are pleased that they will continue to leverage our microarray platform as they scale up their business," said Sam Raha, president of Agilent's Diagnostics and Genomics Group. "Agilent's microarray platform has demonstrated superiority for measurement of DNA and RNA at scale and it is exciting to see how SomaLogic is creatively applying this capability to measure thousands of proteins in a single assay."
"To date we have analyzed over 300,000 human samples as we have built the SOMAscan platform," said Roy Smythe, CEO of SomaLogic. "Agilent custom microarrays have been a critical part of our success to date, and as we now move into health, wellness and disease-monitoring applications for our technology they continue to be an extremely high quality and scalable solution."
Specific details of the agreement were not disclosed.
About SomaLogic
SomaLogic seeks to deliver meaningful and actionable health-management insights that empower individuals worldwide to continuously optimize their personal health and wellness throughout their lives. These essential insights, to be provided through a global network of partners and users, are derived from the precise, proprietary, and personalized measurement of critical changes in an individual's proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 15,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
Contact
Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com
Laura S. Mizoue, Ph.D.
SomaLogic, Inc.
+1.720.417.7509
lmizoue@somalogic.com
Record changed: 2023-07-10 |
Advertisement
More documents for proteomic technology_o
- [1] Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala....
- [2] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....
- [3] Biognosys AG. (8/27/20). "Press Release: Biognosys Announces Nature Communications Publication in Collaboration with ETH Zurich, Bayer, and BASF". Schlieren....
- [4] Fluidic Analytics Ltd.. (9/23/19). "Press Release: Fluidic Analytics Welcomes Dr Joe Keegan as Chairman"....
- [5] Fluidic Analytics Ltd.. (11/26/18). "Press Release: Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases"....
- [6] Fluidic Analytics Ltd.. (9/12/18). "Press Release: Fluidic Analytics Redefines Protein Analysis with the Global Launch of the Fluidity One System"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top